We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

ADVANC:SETAdvanced Info Service Public Co., Ltd. Analysis

Data as of 2026-05-18 - not real-time

$420.99

Latest Price

7/10Risk

Risk Level: Medium

Executive Summary

AMD is trading well above its 20‑day, 50‑day and 200‑day moving averages (price ≈ $421 vs SMAs of $379, $284 and $225), confirming a strong bullish momentum that is also reflected in a bullish MACD crossover and a robust RSI of 66. The stock sits comfortably above its near‑term support at $277 but still has a sizable distance to the 52‑week high resistance around $469, leaving upside potential while the market remains in an overbought zone.
Fundamentally, revenue is expanding at a rapid 38% year‑over‑year and margins are solid, yet the trailing P/E of ~140 dwarfs the industry average of ~38, and a discounted cash‑flow model values the company near $161, indicating a pronounced valuation gap. High beta (≈2.6) and 30‑day volatility above 80% amplify price swings, while the “Extreme Greed” sentiment index suggests speculative enthusiasm. Recent material news points to accelerating AI‑driven demand, record data‑center revenue forecasts, and strategic engagement with Chinese officials, all of which could sustain growth but do not yet close the valuation disparity.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 6/10

Key Factors

  • Bullish technical setup with price above key SMAs
  • RSI in overbought territory suggesting limited immediate upside
  • High short‑term volatility and beta increasing downside risk

Medium Term

1–3 years
Positive
Model confidence: 8/10

Key Factors

  • Strong revenue growth driven by AI and data‑center demand
  • Strategic engagements in China potentially expanding market share
  • Forward P/E compression to ~32 indicating improving earnings outlook

Long Term

> 3 years
Neutral
Model confidence: 7/10

Key Factors

  • Sustained secular growth in high‑performance computing and AI
  • Valuation gap remains wide; price must compress toward fundamentals
  • Sector cyclicality and exposure to geopolitical trade dynamics

Key Metrics & Analysis

Financial Health

Revenue Growth37.80%
Profit Margin13.37%
P/E Ratio139.9
ROE8.06%
ROA3.65%
Debt/Equity6.00
P/B Ratio10.6
Op. Cash Flow$9.7B
Free Cash Flow$7.2B
Industry P/E38.2

Technical Analysis

TrendBullish
RSI66.2
Support$276.62
Resistance$469.22
MA 20$379.01
MA 50$283.78
MA 200$225.41
MACDBullish
VolumeStable
Fear & Greed Index89.61

Valuation

Fair Value$161.19
Target Price$457.83
Upside/Downside8.75%
GradeOvervalued
TypeGrowth

Risk Assessment

Beta2.62
Volatility81.78%
Sector RiskHigh
Reg. RiskMedium
Geo RiskMedium
Currency RiskLow
Liquidity RiskLow

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.